Cardioprotective Effects of Pomegranate (Punica granatum) Juice in Patients with Ischemic Heart Disease

Abstract

Ischemic heart disease is the leading cause of mortality worldwide. The purpose of this study was to evaluate the cardioprotective effects of pomegranate juice in patients with ischemic heart disease. One hundred patients, diagnosed with unstable angina or myocardial infarction, were randomly assigned to the test and the control groups (n = 50, each). During 5 days of hospitalization, in addition to the conventional medical therapies, the test groups received 220 mL pomegranate juice, daily. During the hospitalization period, the blood pressure, heart rate, as well as the intensity, occurrence, and duration of the angina were evaluated on a regular basis. At the end of the hospitalization period, the serum levels of malondialdehyde, interleukin-6, and tumor necrosis factor alpha were measured in all patients. The levels of serum troponin and high-sensitive C-reactive protein levels were also assayed in patients diagnosed with myocardial infarction. Pomegranate juice caused significant reductions in the intensity, occurrence, and duration of angina pectoris in patients with unstable angina. Consistently, the test patients had significantly lower levels of serum troponin and malondialdehyde. Other studied parameters did not change significantly. The results of this study suggest protective effects of pomegranate juice against myocardial ischemia and reperfusion injury. Copyright © 2017 John Wiley & Sons, Ltd.

Pomegranate juice improves cardiometabolic risk factors, biomarkers of oxidative stress and inflammation in hemodialysis patients: a randomized crossover trial

“…Along the same lines as our results, investigations have reported pomegranate antioxidant potential as evidenced by decreased MDA and increased serum total TAC . Likewise, the anti‐inflammatory effect of pomegranate has been shown by reduction of C‐reactive protein and IL‐6, with the latter being an inflammatory biomarker with the maximum predictive value for ESRD outcome .…”

Nitric oxide plays a pivotal role in cardioprotection induced by pomegranate juice against myocardial ischemia and reperfusion

“…In this study, the markers of oxidative stress showed remarkable declines due to pomegranate treatment. Similar results have been reported by other researchers under in vivo conditions (Dong et al, ; Jadeja et al, ) including a clinical trial performed by our team (Razani et al, ). The current study, however, did not investigate the mechanism behind the increased NO levels.…”

“…In another study, pretreatment of rats with Pg for 30 days reduced the markers of cardiac damage and lipid peroxidation and attenuated the infarct size following isoproterenol‐induced myocardial infarction (Jadeja, Thounaojam, Patel, Devkar, & Ramachandran, ). Consistent with the reports in animal studies, we showed in a clinical trial that 5 days of treatment with Pg caused a significant reduction in serum TnI of patients hospitalized for myocardial infarction (Razani et al, ).…”

Antioxidant activity and phenolic composition in pomegranate (Punica granatum L.) genotypes from south Italy by UHPLC–Orbitrap‐MS approach

“…underlined that punicalagin, contained in pomegranate arils, can inhibit neuro‐inflammation related to Alzheimer disease. Moreover, it was reported that pomegranate juice (PJ) exhibits protective effects against lipid oxidation, along with anti‐inflammatory, cardio‐protective, antimicrobial and anti‐infective activities . Several authors reported also a capacity to reduce the concentration of circulatory cytokines and other inflammatory markers in patients with type 2 diabetes .…”